BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang H, Marchal G, Ni Y. Multiparametric MRI biomarkers for measuring vascular disrupting effect on cancer. World J Radiol 2011; 3(1): 1-16 [PMID: 21286490 DOI: 10.4329/wjr.v3.i1.1]
URL: https://www.wjgnet.com/1949-8470/full/v3/i1/1.htm
Number Citing Articles
1
Su Jung Ham, YoonSeok Choi, Seul-I Lee, Jinil Kim, Young Il Kim, Jin Wook Chung, Kyung Won Kim. Enhanced efficacy of radiofrequency ablation for hepatocellular carcinoma using a novel vascular disrupting agent, CKD-516Hepatology International 2017; 11(5): 446 doi: 10.1007/s12072-017-9811-4
2
Roberto García-Figueiras, Anwar R. Padhani, Sandra Baleato-González. Therapy Monitoring with Functional and Molecular MR ImagingMagnetic Resonance Imaging Clinics of North America 2016; 24(1): 261 doi: 10.1016/j.mric.2015.08.003
3
Jeong Min Lee, Jeong-Hee Yoon, Kyung Won Kim. Diagnosis of Hepatocellular Carcinoma: Newer Radiological ToolsSeminars in Oncology 2012; 39(4): 399 doi: 10.1053/j.seminoncol.2012.05.010
4
Nan Yao, Meng Gao, Ke Ren, Xiao Jiang, Yue Li, Cuihua Jiang, Dejian Huang, Wei Liu, Xiaoning Wang, Zhijun Fang, Ziping Sun, Jian Zhang, Yicheng Ni. PD806Anti-Cancer Drugs 2015; 26(2): 148 doi: 10.1097/CAD.0000000000000168
5
Ijin Joo, Jeong Min Lee, Joon Koo Han, Byung Ihn Choi. Intravoxel Incoherent Motion Diffusion-weighted MR Imaging for Monitoring the Therapeutic Efficacy of the Vascular Disrupting Agent CKD-516 in Rabbit VX2 Liver TumorsRadiology 2014; 272(2): 417 doi: 10.1148/radiol.14131165
6
Kathleen Gabrielson, Robert Maronpot, Sébastien Monette, Coraline Mlynarczyk, Yuval Ramot, Abraham Nyska, Polina Sysa-Shah. In Vivo Imaging With Confirmation by Histopathology for Increased Rigor and Reproducibility in Translational Research: A Review of Examples, Options, and ResourcesILAR Journal 2018; 59(1): 80 doi: 10.1093/ilar/ily010
7
Junjie Li, Feng Chen, Yuanbo Feng, Marlein Miranda Cona, Jie Yu, Alfons Verbruggen, Jian Zhang, Raymond Oyen, Yicheng Ni. Diverse Responses to Vascular Disrupting Agent Combretastatin A4 Phosphate: A Comparative Study in Rats with Hepatic and Subcutaneous Tumor Allografts Using MRI Biomarkers, Microangiography, and HistopathologyTranslational Oncology 2013; 6(1): 42 doi: 10.1593/tlo.12367
8
Kyung Won Kim, Jeong Min Lee, Yong Sik Jeon, In Joon Lee, YoonSeok Choi, Jisuk Park, Berthold Kiefer, Chin Kim, Joon Koo Han, Byung Ihn Choi. Vascular disrupting effect of CKD-516: preclinical study using DCE-MRIInvestigational New Drugs 2013; 31(5): 1097 doi: 10.1007/s10637-012-9915-6
9
Yuval Ramot, Yael S. Schiffenbauer, Netanel Amouyal, Nathan Ezov, Michal Steiner, Michal Izrael, Neta Lavon, Arik Hasson, Michel Revel, Abraham Nyska. Compact MRI for the detection of teratoma development following intrathecal human embryonic stem cell injection in NOD-SCID miceNeuroToxicology 2017; 59: 27 doi: 10.1016/j.neuro.2017.01.003
10
Yewei Liu, Frederik De Keyzer, Yixin Wang, Fengna Wang, Yuanbo Feng, Feng Chen, Jie Yu, Jianjun Liu, Shaoli Song, Johan Swinnen, Guy Bormans, Raymond Oyen, Gang Huang, Yicheng Ni. The first study on therapeutic efficacies of a vascular disrupting agent CA4P among primary hepatocellular carcinomas with a full spectrum of differentiation and vascularity: Correlation of MRI‐microangiography‐histopathology in ratsInternational Journal of Cancer 2018; 143(7): 1817 doi: 10.1002/ijc.31567
11
Feng Chen, Yicheng Ni. Cancer Theranostics2014; : 95 doi: 10.1016/B978-0-12-407722-5.00007-4
12
Yewei Liu, Shuncong Wang, Xiaohui Zhao, Yuanbo Feng, Guy Bormans, Johan Swinnen, Raymond Oyen, Gang Huang, Yicheng Ni, Yue Li. Predicting Clinical Efficacy of Vascular Disrupting Agents in Rodent Models of Primary and Secondary Liver Cancers: An Overview with Imaging-Histopathology CorrelationDiagnostics 2020; 10(2): 78 doi: 10.3390/diagnostics10020078
13
In Joon Lee, Myungsu Lee, Soo Jin Kim, You Kyung Kim, Jong Yun Won, Jin Wook Chung. Chemoembolization with Vascular Disrupting Agent CKD-516 Dissolved in Ethiodized Oil in Combination with Doxorubicin: A VX2 Tumor Model StudyJournal of Vascular and Interventional Radiology 2018; 29(8): 1078 doi: 10.1016/j.jvir.2018.03.016
14
Huaijun Wang, Marlein Miranda Cona, Feng Chen, Junjie Li, Jie Yu, Yuanbo Feng, Ronald Peeters, Frederik De Keyzer, Guy Marchal, Yicheng Ni. Comparison Between Nonspecific and Necrosis-avid Gadolinium Contrast Agents in Vascular Disrupting Agent-Induced Necrosis of Rodent Tumors at 3.0TInvestigative Radiology 2011; 46(9): 531 doi: 10.1097/RLI.0b013e31821a2116
15
Jake S. Burrell, Simon Walker‐Samuel, Lauren C.J. Baker, Jessica K.R. Boult, Yann Jamin, Anderson J. Ryan, John C. Waterton, Jane Halliday, Simon P. Robinson. Evaluation of novel combined carbogen USPIO (CUSPIO) imaging biomarkers in assessing the antiangiogenic effects of cediranib (AZD2171) in rat C6 gliomasInternational Journal of Cancer 2012; 131(8): 1854 doi: 10.1002/ijc.27460